Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • FALSE CLAIMS ACT—S.D. Ohio: Relator failed to allege that there was anything illegal about referral exchange
    • AGENCY NEWS—HHS Settles With Dental Practice Over HIPAA Shortfalls
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • AUDITS AND MONITORING—OIG REPORTS: South Carolina underreported federal share of collections subject to increased COVID-19 FMAP
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—PROPOSED RULES: DEA proposes updates to scheduling actions for kratom products, derivatives
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • DRUGS AND BIOLOGICS—FDA GUIDANCE NOTICES: FDA issues guidance on postapproval manufacturing changes
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FALSE CLAIMS ACT—SETTLEMENT AGREEMENTS: AIDS Healthcare Foundation to pay $1.44M to settle FCA allegations
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FRAUD AND ABUSE—DAB DECISIONS: Health care fraud conviction supports 23-year exclusion
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • LABELING AND PACKAGING (FOOD, DRUGS & MEDICAL DEVICES)—N.D. Cal.: False advertising action concerning “naturally flavored” candy product may proceed in part
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: Classification of the infant pulse rate, oxygen saturation monitor for OTC use
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: Classification of the system for detection of nucleic acid from non-viral microorganism(s) causing sexually transmitted infections using home-collected specimens
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, DRUGS AND BIOLOGICS—FDA GUIDANCE NOTICES: FDA issues guidance on postapproval manufacturing changes, (Oct 14, 2026)

    By WK Editorial Staff

    The FDA announced the availability of a final guidance for industry entitled “Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers.”

    This guidance provides answers to commonly as ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use